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http://dx.doi.org/10.1016/j.jfma.201
0929-6646/Copyright ª 2015, ElsevierBackground/purpose: Macrocytosis is defined as having the mean corpuscular volume (MCV) 
100 fL. This study assessed hematinic deficiencies and pernicious anemia (PA) in oral mucosal
disease patients with macrocytosis.
Methods: The blood hemoglobin (Hb), iron, vitamin B12, folic acid, and homocysteine concen-
trations and MCV in 60 oral mucosal disease patients with macrocytosis were measured and
compared with the corresponding data in 120 age- and sex-matched healthy control partici-
pants. PA was defined by the World Health Organization (WHO) as having an Hb concentration
< 13 g/dL for men and < 12 g/dL for women, an MCV  100 fL, a serum vitamin B12 level <
200 pg/mL, and serum gastric parietal cell antibody (GPCA) positivity.
Results: We found that 30 (50.0%), 7 (11.7%), 24 (40.0%), and three (5.0%) oral mucosal disease
patients with macrocytosis had deficiencies of Hb (men < 13 g/dL, women < 12 g/dL), iron (<
60 mg/dL), vitamin B12 (< 200 pg/mL), and folic acid (< 4 mg/mL), respectively. Moreover, 38
(63.3%) and 16 (26.7%) macrocytosis patients had abnormally high blood homocysteine level (>
12.3 mM) and serum GPCA positivity, respectively. Macrocytosis patients had a significantly
higher frequency of Hb, iron, or vitamin B12 deficiency, of abnormally elevated blood homo-
cysteine level, and of GPCA positivity than healthy control participants (p < 0.001). However,
only 16.7% of 60 macrocytosis patients were diagnosed as having PA by the WHO definition.
Conclusion: Only 16.7% of oral mucosal disease patients with macrocytosis are discovered to
have PA by the WHO definition.
Copyright ª 2015, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.have no conflicts of interest relevant to this article.
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Macrocytic anemia 737IntroductionMacrocytosis is a blood condition in which erythrocytes are
larger than normal. It has been defined as having the mean
corpuscular volume (MCV)  100 fL.1e3 Patients with
macrocytosis may or may not have anemia. In fact, eryth-
rocytes of newborns, infants, and women during pregnancy
tend to be larger than normal adult erythrocytes.1,3
Macrocytosis with associated anemia (macrocytic anemia)
can be divided into megaloblastic and nonmegaloblastic
anemia, based on the examination of the bone marrow. The
etiologies of macrocytic anemia include nutritional de-
ficiencies (vitamin B12 and folic acid), drugs (e.g.,
chemotherapeutic, antiretroviral, and antimicrobial
agents), primary bone marrow disorders (e.g., myelodys-
plasia and leukemia), and other chronic illness (such as
alcoholism and hypothyroidism).1e3 As multiple causes are
involved in macrocytosis, it is important to determine the
pivotal cause of macrocytosis for giving each macrocytosis
patient an appropriate treatment.
Folic acid deficiency results from poor nutritional
intake, malabsorption, hepatobiliary dysfunction,
increased folate catabolism, and medication (e.g., meth-
otrexate, 5-fluoro-uracil, phenytoin, etc.).2 Causes of
vitamin B12 deficiency include inadequate intake (espe-
cially for strict vegetarians), food-bound vitamin B12
malabsorption (for those with prolonged use of proton
pump inhibitors or histamine H2 receptor blockers), lack of
intrinsic factor or parietal cells (for patients with pernicious
anemia, atrophic gastritis, or gastrectomy), ileal malab-
sorption (for patients with enteritis or ileal resection),
biologic competition (including bacterial overgrowth and
tapeworm infestation), and defective transport (such as
transcobalamin II deficiency).4 The intrinsic factor, which is
produced by the parietal cells of the stomach lining, can
avidly bind dietary vitamin B12. The vitamin B12-intrinsic
factor complex is carried to the terminal ileum, where it
is absorbed after binding to intrinsic factor receptors on the
luminal membranes of ileal cells.4 Vitamin B12 deficiency
may lead to pernicious anemia (PA). In PA patients, there
are two mechanisms that cause the intrinsic factor defi-
ciency or inactivation: (1),w85% of PA patients possess the
gastric parietal cell antibodies (GPCA) that induce
destruction of parietal cells and in turn result in failure of
intrinsic factor production;5,6 (2) 40e80% of PA patients
have intrinsic factor antibodies that bind to the vitamin
B12-binding site of intrinsic factor and subsequently inac-
tivate the vitamin B12 absorption-aiding function of
intrinsic factor.7,8
In our oral mucosal disease clinic, there are many pa-
tients with burning mouth syndrome (BMS), recurrent aph-
thous ulcerations (RAU), atrophic glossitis (AG), or oral
lichen planus (OLP). For these patients, complete blood
count and examination of serum iron, vitamin B12, folic
acid, and homocysteine levels are usually ordered to check
whether these patients have microcytic or macrocytic
anemia, thalassemia, and deficiencies of hematinics.9e18 If
oral mucosal disease patients have hematinic deficiencies,
multiple hematinic supplement therapy frequently results
in correction of anemic status and improvement of oral
symptoms and signs.19,20 Although not often encountered,macrocytosis patients are sometimes discovered in our oral
mucosal disease clinic. For these oral mucosal disease pa-
tients with macrocytosis, it was interesting to investigate
whether these patients might have anemia, hematinic de-
ficiencies, and specific oral manifestations, what percent-
ages of these patients might have anemia, hematinic
deficiencies, and specific oral manifestations, and what the
main etiological factor causing macrocytosis was in these
patients. In this study, 60 oral mucosal disease patients
with macrocytosis (MCV  100 fL) were collected from the
oral mucosal disease clinic of the National Taiwan Univer-
sity Hospital (NTUH), Taipei, Taiwan. Their oral manifes-
tations (including burning sensation and numbness of oral
mucosa, dry mouth, and dysfunction of taste) and specific
oral mucosal diseases (such as BMS, RAU, AG, and OLP),
MCV, blood levels of hemoglobin (Hb), iron, vitamin B12,
folic acid, and homocysteine were inquired, examined, and
recorded. These data were compared with corresponding
data of 120 age- and sex-matched healthy control partici-
pants without oral mucosal and systemic diseases to assess
whether macrocytosis patients had higher frequencies of
anemia, hematinic deficiencies, specific oral manifesta-
tions, and oral mucosal diseases compared with healthy
control participants and to evaluate whether all oral
mucosal disease patients with macrocytosis had PA or not.
Materials and methods
Participants
The study group consisted of 60 oral mucosal disease pa-
tients (18 men and 42 women, age range 22e84 years,
mean 57.8  10.6 years) with macrocytosis (MCV  100 fL).
For each patient, two age- ( 2 years of each patient’s age)
and sex-matched healthy control participants were
selected. Thus, the normal control group consisted of 120
healthy control participants (36 men and 84 women, age
range 21e84 years, mean 56.2  13.8 years). All the pa-
tients and healthy control participants were seen consec-
utively, diagnosed, treated, and selected in the oral
mucosal disease clinic of NTUH from July 2007 to June
2014. The 60 oral mucosal disease patients with macrocy-
tosis had one or two oral diseases including BMS, AG, RAU,
and OLP. BMS was diagnosed when patients had a burning
sensation of the oral mucosa in the absence of clinically
apparent mucosal alterations.9,19 Patients were diagnosed
as having partial or complete AG when their dorsal tongues
showed partial or complete absence or flattening of filiform
papillae, respectively.11,20 RAU was diagnosed when pa-
tients had at least one episode of oral ulcerations per
month during the preceding years.10 OLP was diagnosed
according to the following criteria: (1) a typical clinical
presentation of radiating grayish-white Wickham striae or
papules (nonerosive OLP) combined with erosion or ulcer-
ation on the bilateral buccal or vestibular mucosa (erosive
OLP); and (2) biopsy specimens characteristic of OLP, i.e.,
hyperkeratosis or parakeratosis, a slightly acanthotic
epithelium with liquefaction degeneration of the basal
epithelial cells, a pronounced band-like lymphocytic infil-
trate in the lamina propria, and the absence of epithelial
dysplasia.12e14 However, all macrocytosis patients with
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systemic lupus erythematosus, rheumatoid arthritis, Sjog-
ren’s syndrome, pemphigus vulgaris, and cicatricial pem-
phigoid), inflammatory diseases, malignancy, or recent
surgery were excluded. In addition, all macrocytosis pa-
tients with serum creatinine concentrations indicative of
renal dysfunction (i.e., men, > 131 mmol/L; women, >
115 mmol/L), and who reported a history of stroke, heavy
alcohol use, or diseases of the liver, kidney, or coronary
arteries were also excluded.21 Healthy control participants
had either dental caries or mild periodontal diseases but
did not have any oral mucosal or systemic diseases. None of
our macrocytosis patients had taken any prescription
medication for malignancies, epilepsy, diabetes mellitus,
infection, inflammation, BMS, AG, RAU, or OLP at least 3
months before entering the study.
According to the aforementioned diagnostic criteria, the
60 oral mucosal disease patients with macrocytosis
included 30 with AG only, 17 with BMS only, two with OLP
only, four with RAU and AG, one with RAU and BMS, and six
with both OLP and AG. For all oral mucosal disease patients
with macrocytosis and healthy control participants, oral
manifestations including burning sensation and numbness
of oral mucosa, dry mouth, dysfunction of taste, AG, RAU,
and OLP were inquired, examined, and recorded. The blood
samples were drawn from all patients and healthy control
participants for measurement of complete blood count,
blood iron, vitamin B12, folic acid, and homocysteine
concentrations. All patients and healthy control partici-
pants signed the informed consents before entering the
study. This study was reviewed and approved by the Insti-
tutional Review Board at the NTUH.
Determination of complete blood count and blood
iron, vitamin B12, folic acid, and homocysteine
concentrations
The complete blood count and blood iron, vitamin B12, folic
acid, and homocysteine concentrations were determined
by the routine tests performed in the Department of Lab-
oratory Medicine of NTUH.
Determination of serum gastric parietal cell
antibody level
The serum GPCA level was detected by the indirect
immunofluorescence technique with rat stomach as a sub-
strate as described previously.11,17 In brief, 5 mm-thick
cryostat sections of substrate tissues on slides were reacted
with serially diluted patients’ and control participants’ sera
in a moist chamber at room temperature for 30 minutes.
The initial dilution of the patients’ and control partici-
pants’ sera was 1:20 with phosphate-buffered saline (PBS).
After washing, the sections were incubated with fluorescein
isothiocyanate (FITC)-labeled goat antihuman immuno-
globulin G antiserum (Boehringer Mannheim Biochemicals,
Indianapolis, IN, USA) which had been prediluted and kept
in dropper vial by the manufacturer and was ready-to-use
for another 30 minutes. The sections were washed again,
mounted with buffered glycerine, and examined with an
Olympus fluorescence microscope (Olympus, Tokyo,Japan). Sera were scored as positive when they produced
fluorescence at a dilution of 20-fold or more.
Statistical analysis
Comparisons of the MCV and mean blood levels of Hb, iron,
vitamin B12, folic acid, and homocysteine between 60 oral
mucosal disease patients with macrocytosis and 120 age-
and sex-matched healthy control participants were per-
formed by Student t test. The differences in frequency of
Hb, vitamin B12, or folic acid deficiency, of abnormally high
blood homocysteine level, or of GPCA positivity between 60
oral mucosal disease patients with macrocytosis and 120
age- and sex-matched healthy control participants were
compared by Chi-square test. In addition, the difference in
frequency of each oral manifestation between 60 oral
mucosal disease patients with macrocytosis and 120 age-
and sex- matched healthy control participants were also
compared by Chi-square test. The result was considered to
be significant if p < 0.05.
Results
The MCV and mean blood concentrations of Hb, iron,
vitamin B12, folic acid, and homocysteine in 60 oral
mucosal disease patients with macrocytosis and in 120 age-
and sex-matched healthy control participants are shown in
Table 1. As men usually had higher blood levels of Hb and
iron than women, these two mean levels were calculated
separately for men and women. We found that oral mucosal
disease patients with macrocytosis had a significantly
higher MCV (104.4  6.6 fL) than that (90.8  3.4 fL,
p < 0.001) of healthy control participants. Moreover,
significantly lower mean Hb level (for both men and
women, p < 0.001) and mean vitamin B12 level (p < 0.001)
as well as significantly higher mean blood homocysteine
level (p < 0.001) were found in oral mucosal disease pa-
tients with macrocytosis than in healthy control partici-
pants (Table 1). However, no significant difference in the
mean blood iron or folic acid level was discovered between
60 oral mucosal disease patients with macrocytosis and 120
healthy control participants (Table 1).
According to the World Health Organization (WHO)
criteria, men with Hb < 13 g/dL and women with Hb < 12 g/
dL were defined as having hemoglobin deficiency or ane-
mia.22 Furthermore, patients with serum iron level < 60 mg/
dL,23 serum vitamin B12 level < 200 pg/mL (148 pmol/L),21
or folic acid level < 4 ng/mL (10 nmol/L)24 were defined as
having iron, vitamin B12, or folic acid deficiency, respec-
tively (Table 2). In addition, patients with the blood ho-
mocysteine level > 12.3 mmol/L (which was the mean blood
homocysteine level of healthy control participants plus 2
standard deviations) were defined as having abnormally
high homocysteine levels. By the above-mentioned defini-
tions, 30 (50.0%), seven (11.7%), 24 (40.0%), and three
(5.0%) of 60 oral mucosal disease patients with macrocy-
tosis had Hb, iron, vitamin B12, and folic acid deficiencies,
respectively. However, none of the normal control partici-
pants was diagnosed as having Hb, iron, vitamin B12, and
folic acid deficiencies by the aforementioned strict WHO
criteria. Moreover, oral mucosal disease patients with
Table 1 The mean corpuscular volume (MCV) and mean blood concentrations of hemoglobin (Hb), iron, vitamin B12, folic
acid, and homocysteine in our 60 patients with macrocytosis (MCV  100 fL) and in 120 age- and sex-matched healthy control
participants.
Factor Macrocytosis patients (n Z 60) Healthy controls (n Z 120) p
(Student t test)Mean  SD Range Mean  SD Range
MCV (fL) 104.4  6.6 100.0e136.8 90.8  3.4 82.4e98.6 < 0.001
Hb (g/dL)
Male 12.4  1.7 (n Z 18) 8.7e15.7 15.1  0.6 (n Z 36) 13.8e16.3 < 0.001
Female 12.2  1.3 (n Z 42) 9.2e14.6 13.6  0.7 (n Z 84) 12.2e15.2 < 0.001
Iron (mg/dL)
Male 97.9  39.2 (n Z 18) 41.0e183.0 100.3  24.0 (n Z 36) 65.0e151.0 0.782
Female 99.3  40.6 (n Z 42) 25.0e239.0 95.6  26.3 (n Z 84) 60.0e204.0 0.539
Vitamin B12 (pg/mL) 450.1  321.5 150.0e1000.0 657.0  223.3 259.0e1000.0 < 0.001
Folic acid (ng/mL) 14.6  7.2 2.0e24.0 14.1  5.8 4.1e24.0 0.616
Homocysteine (mM) 26.0  31.7 4.5e174.0 8.5  1.9 4.5e13.4 < 0.001
Macrocytic anemia 739macrocytosis had a significantly higher frequency of he-
moglobin, iron, or vitamin B12 deficiency, of abnormally
elevated blood homocysteine level, and of gastric parietal
cell antibody (GPCA) positivity than the healthy control
participants (all p-values< 0.001, Table 2).
In this study, 30 (50%) oral mucosal disease patients with
macrocytosis were diagnosed as having anemia according to
the WHO criteria.22 If pernicious anemia is defined as the
presence of a Hb concentration < 13 g/dL for men and <
12 g/dL for women,22 a mean corpuscular volume  100 fL,
a low serum vitamin B12 level (< 200 pg/mL), and serum
GPCA positivity,17 we discovered that only 10 (16.7%) of the
60 oral mucosal disease patients with macrocytosis could be
classified as having pernicious anemia.
The oral manifestations in 60 oral mucosal disease pa-
tients with macrocytosis and in 120 healthy control par-
ticipants are shown in Table 3. We found that oral mucosal
disease patients with macrocytosis had significantly higher
frequencies of all oral manifestations than the healthy
control participants (p < 0.001), in which burning sensation
of oral mucosa (100.0%), dry mouth (75.0%), and AG (66.7%)
were the three leading oral manifestations for macrocytosis
patients (Table 3).Table 2 Number and percentage of individuals with hemoglobin
high homocysteine level, or with serum gastric parietal cell ant
(MCV  100 fL) and in 120 age- and sex-matched healthy control
Factor Pa
Macrocytosis patients
Hemoglobin deficiency (male < 13 g/dL,
female < 12 g/dL)
30 (50.0)
Iron deficiency (< 60 mg/dL) 7 (11.7)
Vitamin B12 deficiency (< 200 pg/mL) 24 (40.0)
Folic acid deficiency (< 4 ng/mL) 3 (5.0)
High homocysteine level (> 12.3 mM)a 38 (63.3)
GPCA positivity 16 (26.7)
MCV Z mean corpuscular volume.
a High homocysteine level was defined as patients with the homocyst
control participants plus two standard deviations.Discussion
This study found that 30 and 10 of the 60 oral mucosal
disease patients with macrocytosis had anemia (men with
Hb < 13 g/dL and women with Hb < 12 g/dL) and PA,
respectively. Of the 30 anemic macrocytosis patients, 14
had only vitamin B12 deficiency (serum vitamin B12 level <
200 pg/mL), five had both vitamin B12 and iron deficiencies
(serum iron level < 60 mg/dL), 10 had serum GPCA posi-
tivity, and none had folic acid deficiency. These findings
suggest that only a half of 60 oral mucosal disease patients
with macrocytosis have anemia. The causes of anemia in
these 30 anemic macrocytosis patients are either vitamin
B12 deficiency (19 patients, 63.3%) or iron deficiency (5
patients, 16.7%). Folic acid deficiency is not the cause of
anemia in these 30 anemic macrocytosis patients. As only
10 of the 30 anemic macrocytosis patients were GPCA-
positive, the GPCA positivity was the determinant factor of
having PA in these 30 anemic macrocytosis patients. In
addition, we also found that 24 (40.0%) of our 60 oral
mucosal disease patients with macrocytosis had vitamin
B12 deficiency. Of these 24 macrocytosis patients with
vitamin B12 deficiency, only 11 had serum GPCA positivity, iron, vitamin B12, or folic acid deficiency, with abnormally
ibody (GPCA) positivity in our 60 patients with macrocytosis
participants.
rticipant number (%) p
(Chi-square test)(n Z 60) Healthy controls (n Z 120)
0 (0) < 0.001
0 (0) < 0.001
0 (0) < 0.001
0 (0) 0.064
2 (1.7) < 0.001
2 (1.7) < 0.001
eine level greater than the mean of homocysteine level of healthy
Table 3 Oral manifestations in our 60 patients with macrocytosis (MCV  100 fL) and in 120 age- and sex-matched healthy
control participants.
Oral manifestation Participant number (%) p
(Chi-square test)Macrocytosis patients (n Z 60) Healthy controls (n Z 120)
Burning sensation 60 (100.0) 0 (0) < 0.001
Dry mouth 45 (75.0) 0 (0) < 0.001
Atrophic glossitis 40 (66.7) 0 (0) < 0.001
Numbness 26 (43.3) 0 (0) < 0.001
Dysfunction of taste 16 (26.7) 0 (0) < 0.001
Oral lichen planus 8 (13.3) 0 (0) < 0.001
Recurrent aphthous ulcerations 5 (8.3) 0 (0) 0.006
MCV Z mean corpuscular volume.
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presence of GPCA). Thus, the vitamin B12 deficiency in the
other 13 GPCA-negative macrocytosis patients may be due
to other causes including inadequate intake or malabsorp-
tion of vitamin B12, the presence of anti-intrinsic factor
antibodies, or transcobalamin II deficiency, etc.4 Further-
more, because none of our oral mucosal disease patients
with macrocytosis had both vitamin B12 and folic acid de-
ficiencies, the macrocytic RBCs in our macrocytosis patients
can only be partially explained by vitamin B12 (24 patients,
40.0%) or folic acid (3 patients, 5.0%) deficiency which re-
sults in a significantly reduced production of Hb and gen-
eration of macrocytic RBC.1e3 The causes of macrocytosis in
the other 33 macrocytosis patients without both vitamin
B12 and folic acid deficiencies may be alcoholism, medi-
cations, bone marrow dysplasia, reticulocytosis, hypothy-
roidism, or nonalcoholic liver disease, etc.1e3 Further
studies such as reticulocyte count, checking of methyl-
malonic acid level, and bone marrow biopsy are needed to
determine the exact cause of macrocytosis in these 33
macrocytosis patients without both vitamin B12 and folic
acid deficiencies.1e3
Homocysteine is a sulfur-containing amino acid which is
formed during methionine metabolism.25 Both vitamin B12
and folic acid act as coenzymes for the conversion of ho-
mocysteine to methionine.26 Higher blood homocysteine
levels can cause oxidative stress, damage endothelium, and
enhance thrombogenicity in experimental studies, and thus
are associated with increased rates of coronary heart dis-
ease and stroke.25,27e30 Moreover, measurement of both
serum methylmalonic acid and homocysteine levels is
discovered to be a more sensitive method of screening for
vitamin B12 deficiency with the sensitivity being 99.8% and
thus can be used for detecting subclinical vitamin B12
deficiency.4,31 In this study, an abnormally higher blood
homocysteine level was detected in 38 (63.3%) of the 60
oral mucosal disease patients with macrocytosis but could
be found in only two (1.7%) of the 120 healthy control
participants. The high blood homocysteine level in patients
is found to be due to deficiencies in folic acid, vitamin B12,
and vitamin B6, because a supplement therapy with folic
acid, vitamin B12, and vitamin B6 to patients can reduce
blood homocysteine levels.19,20,27 Our study showed a
significantly higher frequency of vitamin B12 deficiency
(40.0%) and a marginally significantly higher frequency of
folic acid deficiency (5.0%) in our 60 oral mucosal diseasepatients with macrocytosis than in healthy control partici-
pants. Moreover, our oral mucosal disease patients with
macrocytosis also had a significantly lower mean serum
vitamin B12 level than that of healthy control participants.
Therefore, the high blood homocysteine level in our oral
mucosal disease patients with macrocytosis was mainly due
to deficiency of vitamin B12 and very minor due to defi-
ciency of folic acid.
This study showed significantly higher frequencies of all
oral manifestations in our oral mucosal disease patients
with macrocytosis than in healthy control participants
(p < 0.001). These oral manifestations included burning
sensation of oral mucosa (100.0%), dry mouth (75.0%), AG
(66.7%), numbness of oral mucosa (43.3%), dysfunction of
taste (26.7%), OLP (13.3%), and RAU (8.3%). Our previous
studies found burning sensation of oral mucosa, dry mouth,
numbness of oral mucosa, and dysfunction of taste in 100%,
75.7%, 43.9%, and 19.8% of 399 BMS patients, respectively;9
and in 100%, 79.0%, 57.4%, and 27.8% of 176 AG patients,
respectively.11 As 66.7%, 30.0%, 13.3%, and 8.3% of our 60
macrocytosis patients had concomitant AG, BMS, OLP and
RAU, this could explain why our oral mucosal disease pa-
tients with macrocytosis had significantly higher fre-
quencies of all oral manifestations including burning
sensation of oral mucosa, dry mouth, numbness of oral
mucosa, and dysfunction of taste than healthy control
participants. In addition, 50% of our 60 macrocytosis pa-
tients had anemia according to the WHO criteria.22 Anemia
patients have reduced hemoglobins which carry insufficient
oxygen to oral mucosa and finally results in atrophy of oral
mucosa.15 Moreover, 11.7%, 40.0%, and 5% of our 60 oral
mucosal disease patients with macrocytosis had iron,
vitamin B12, and folic acid deficiency. Iron is essential to
the normal functioning of oral epithelial cells15 and both
vitamin B12 and folic acid play important roles in DNA
synthesis and cell division.1e3,8,21 Oral epithelial cells have
a high turnover rate. Therefore, deficiencies of iron,
vitamin B12, and folic acid may result in oral epithelial
atrophy. Furthermore, high blood homocysteine level may
result in an elevated frequency of thrombosis in the feeding
arterioles that supply the nutrients to the oral epithelial
cells.25,27e30 This in turn leads to oral epithelial atrophy.
Atrophic tongue dorsal or other oral mucosa in macrocytosis
patients could partially explain why a significant number of
our oral mucosal disease patients with macrocytosis had a
burning sensation, numbness of oral mucosa, and
Macrocytic anemia 741dysfunction of taste.11 The reasons why BMS and AG pa-
tients may have more burning sensation and numbness of
oral mucosa, dry mouth, and dysfunction of taste than
healthy control participants have been explained in detail
in our previous papers.9,11
Our results demonstrated that 50.0%, 11.7%, 40.0%, and
5.0% of our 60 oral mucosal disease patients with macro-
cytosis had deficiencies of Hb, iron, vitamin B12, and folic
acid, respectively. Moreover, 63.3% and 26.7% of our 60 oral
mucosal disease patients with macrocytosis had abnormally
high blood homocysteine level and serum GPCA positivity,
respectively. We also found significantly higher frequencies
of Hb, iron, and vitamin B12 deficiencies, of abnormally
elevated blood homocysteine level, and of GPCA positivity
in our 60 oral mucosal disease patients with macrocytosis
than in 120 healthy control participants. These findings
suggest there is a significant association of deficiencies of
Hb, iron, and vitamin B12 as well as of abnormally high
blood homocysteine level and serum GPCA positivity with
macrocytosis. However, only 16.7% of our 60 oral mucosal
disease patients with macrocytosis were diagnosed as
having PA by the strict WHO definition.References
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